Search

for
Search:

GlossaryDupilumab

monoclonal antibody treating inflammatory conditions like eczema and asthma

Dupilumab is a monoclonal antibody medication used to treat certain inflammatory conditions like eczema (atopic dermatitis) and asthma. It works by blocking specific proteins (IL-4 and IL-13) involved in the body's immune response, thereby reducing inflammation and symptoms.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 180 results

research Alopecia Areata After Dupilumab for Atopic Dermatitis

53 citations, January 2018 in “JAAD case reports”

Dupilumab for eczema may cause hair loss.

research Dupilumab: A Review of Present Indications and Off-Label Uses

50 citations, March 2021 in “Journal of investigational allergology & clinical immunology”

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

research Drug-Induced Alopecia After Dupilumab Therapy

49 citations, December 2018 in “JAAD case reports”

Dupilumab may cause significant hair loss, which can reverse after stopping the drug.

research Dupilumab Improved Alopecia Areata in a Patient with Atopic Dermatitis: A Case Report

33 citations, January 2019 in “Acta Dermato Venereologica”

Dupilumab may help regrow hair in people with atopic dermatitis.

research Dupilumab And Alopecia: A Janus Effect

29 citations, July 2019 in “Dermatologic Therapy”

Dupilumab can both heal and cause hair loss.

View more "dupilumab" in research →

Community Join

1 / 1 results

community 2020 Hair and Scalp Treatments: A Clinical Guide (in Depth 350 Page Guide)

in Treatment 62 upvotes 4 years ago

Treatments for hair loss, including topical immunotherapy, regenerative treatments, laser and light-based therapies, oral supplements, intralesional steroids, and new drugs like finasteride and minoxidil.